GlassScriptPhysician profile
Danny A Sherwinter
NPI 1477597581
$35,665.13
in general payments reported to CMS, 2019-2025
33 companies · $387 in 2025
The $387 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,403 · 2020: $10K · 2021: $9,123 · 2022: $7,790 · 2023: $3,424 · 2024: $1,053 · 2025: $387.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $3,000 · Food and Beverage: $962 · Travel and Lodging: $722 · Education: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $3,000.00 |
| Food and Beverage | $962.18 |
| Travel and Lodging | $722.38 |
| Education | $180.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vioptix INC | $12,627.25 | 2021-2022 | |
| Stryker Corporation | $10,308.00 | 2020 | |
| Flexdex INC. | $5,274.39 | 2022-2023 | |
| Wilson Cook Medical Incorporated | $2,620.00 | 2019-2022 | |
| Medtronic, INC. | $1,163.33 | 2021-2025 | Signia, Ligasure |
| Intuitive Surgical, INC. | $893.02 | 2019-2024 | |
| Covidien LP | $467.65 | 2019-2020 | |
| Intra-Sana Laboratories | $312.16 | 2022-2023 | Reltone 200 Mg, Reltone 400 Mg, Glycate |
| Allergan, INC. | $220.64 | 2019-2022 | |
| Ethicon US, LLC | $192.60 | 2019-2025 | Vistaseal, Stratafix |
| Takeda Pharmaceuticals U.S.A., INC. | $178.62 | 2021-2025 | Gattex |
| Cook Medical LLC | $164.70 | 2019 | |
| Acell, INC. | $142.74 | 2019-2020 | |
| Csl Behring | $123.22 | 2023-2024 | Kcentra |
| Integra Lifesciences Corporation | $114.44 | 2021-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $110.93 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $98.68 | 2025 | |
| Daiichi Sankyo INC. | $70.84 | 2019 | |
| Procept Biorobotics Corporation | $64.28 | 2023 | Aquabeam Robotic System |
| Boston Scientific Corporation | $63.33 | 2020-2022 | |
| Teleflex LLC | $55.82 | 2020-2024 | Titan Sgs |
| Heron Therapeutics, INC. | $54.52 | 2023-2024 | Zynrelef |
| Davol INC. | $46.25 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $40.72 | 2023-2024 | Caldolor |
| Innocoll Pharmaceuticals Limited | $38.00 | 2022 | |
| Baxter Healthcare | $35.79 | 2025 | Tisseel |
| Olympus America INC. | $33.46 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $32.79 | 2025 | |
| Polynovo North America LLC | $30.73 | 2021 | |
| Abbvie INC. | $27.39 | 2024 | |
| Trevena, INC. | $24.00 | 2021 | |
| Mallinckrodt Hospital Products INC. | $20.59 | 2020 | |
| Merck Sharp & Dohme LLC | $14.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danny Sherwinter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.